Danaher's Beckman Coulter wins FDA clearance for bacterial-viral infection test
DHR•Danaher unit Beckman Coulter Diagnostics received FDA clearance for its Access MeMed BV blood test, which distinguishes bacterial from viral infections and delivers results in as little as 15 minutes.
1. Test receives clearance
Beckman Coulter Diagnostics received FDA clearance for its Access MeMed BV blood test to distinguish bacterial from viral infections. It is cleared for adults and children aged 90 days or older and delivers results in as little as 15 minutes. The test runs on existing DxI 9000 and Access 2 analyzers without requiring new instruments or workflow changes.
